KVUE · Kenvue Inc.
$19.18
-0.49 (-2.49%)
At close · Aug 6
Market Cap
$36.84B
Shares
1.92B
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$19.18
Open$19.54
Day$19.01–19.70
52W$13.53–21.18
Avg vol 30d20.9M
Short int61.6M · 3.2% float · 3.3d
Short vol47%
Last earningsAug 6, 2026
DataMay 2023–Aug 2026
Filing10-Q · Aug 6
Up next
Next earnings call
Nov 4, 2026
Est · unconfirmed
· in 13 wks
FQ3-27 quarter ends
~Oct 3, 2026
Est
filed Aug 6, 2026
Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Bearish
Fundamentals
Strong
Quant / Vol
Moderate
Market backdrop
VIX 15.2 · calm
Equity put/call 0.60
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+9%
above
Price vs 50-day avg
+3%
above
RSI (14)
51
neutral
MACD trend
Negative
52-week position
74%
mid-range
Momentum
relative strength
1-month return
0%
trailing
6-month return
+5%
trailing
YTD return
+14%
this year
Relative strength
−8%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $19 › 200d $18 — 50d above 200d
Institutional flow
Distributing
518 of 1,014 funds reported for Jun 30 · net -14.3M sh shares · +52 new
Insider flow
Distributing
Net -$67.0K over 90 days · 100% sells
Short interest
Rising
3.20% of float · ▲ +5.0% MoM · 3.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1,014 holders — mid 4-yr range
Squeeze score
63
elevated · 0–100
Fundamentals
Revenue growth
−2%
Y/Y
Gross margin
58%
expanding
EPS growth
+41%
Y/Y
Free cash flow
$1.7B
Valuation
P/E 22.3
below peers
Balance sheet
$8.1B
net debt
Quant / Vol
risk profile
Volatility
33%
annualized · 1-yr
Max drawdown
−35%
past year
ATR
2.7%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+9%
Bullish
Price vs 50-day avg
+3%
Bullish
RSI (14)
51
Neutral
MACD trend
Negative
Bearish
52-week position
74%
Neutral
Market signals — smart money & positioning
Bearish · 3 of 6
Trend (MA cross)
No cross
50d $19 › 200d $18 — 50d above 200d
Institutional flow
Distributing
518 of 1,014 funds reported for Jun 30 · net -14.3M sh shares · +52 new
Insider flow
Distributing
Net -$67.0K over 90 days · 100% sells
Short interest
Rising
3.20% of float · ▲ +5.0% MoM · 3.3 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
1,014 holders — mid 4-yr range
Price context
position in its 52-week range
52-wk low $14
Now $19 · 74%
52-wk high $21
vs 200-day avg +9%
vs 50-day avg +3%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted diluted earnings per share non-GAAP | $0.31 | Second quarter 2026 | — |
|
|
|||
| Adjusted gross profit margin non-GAAP | 60.2% | Second quarter 2026 | — |
|
|
|||
| Adjusted operating income non-GAAP | $873M | Fiscal Three Months Ended June 28, 2026 | — |
| Adjusted operating income margin non-GAAP | 22.1% | Second quarter 2026 | — |
|
|
|||
| Essential Health Adjusted operating income non-GAAP | $315M | Fiscal Three Months Ended June 28, 2026 | — |
| Organic sales change non-GAAP | 1.6% | Fiscal Three Months Ended June 28, 2026 | — |
| Self Care Adjusted operating income non-GAAP | $512M | Fiscal Three Months Ended June 28, 2026 | — |
| Skin Health and Beauty Adjusted operating income non-GAAP | $186M | Fiscal Three Months Ended June 28, 2026 | — |
| Adjusted effective tax rate non-GAAP | 27.2% | First quarter 2026 | — |
|
|
|||
| Free cash flow non-GAAP | 0.4B | First quarter 2026 | — |
| Organic sales non-GAAP | 0.7% | First quarter 2026 | — |
| EBITDA (non-GAAP) non-GAAP | $663M | Fiscal Three Months Ended December 28, 2025 | — |
| EBITDA margin (non-GAAP) non-GAAP | 17.5% | Fiscal Three Months Ended December 28, 2025 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Household & Personal Products — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
KVUE
this stock
Kenvue Inc.
|
$36.84B | +13.8% | -2.1% | 22.3 | 3.2% |
|
PG
PROCTER & GAMBLE Co
|
$341.62B | +4.8% | +3.3% | 22.2 | 1.0% |
|
UL
Unilever PLC
|
$138.80B | -1.0% | — | — | 0.1% |
|
CL
Colgate Palmolive Co
|
$74.14B | +19.8% | +1.7% | 36.8 | 2.1% |
|
KMB
Kimberly Clark Corp
|
$36.14B | +10.5% | +2.0% | 18.5 | 13.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| KVUE | -0.7% | +0.0% | +4.6% | -0.3% | +13.8% |
| SPY | +3.6% | +2.2% | +12.8% | +2.9% | +12.7% |
| vs SPY | -4.3% | -2.2% | -8.2% | -3.2% | +1.1% |
Capital returns
Latest dividend
$0.208
/ share · ex May 13, 2026
Paid (TTM)
$0.832
/ share · 4 payouts
Dividend yield (TTM, derived)
4.34%
Buyback program
· as of Dec 28, 2025
Authorized
shares 27.00M
Spent (derived)
—
Remaining
—
Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.
Key facts
CIK
1944048
CUSIP
49177J102
13F (30d)
452 filings
446 filers
Visit website
Investor relations